Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

BAP1 inhibits DGC. 2 / 2

| 2

➶

reach

"As in NCI-H226 cells, 25 BAP1 expression suppressed the growth of our DGC cells, suggesting that BAP1 is a novel tumor suppressor candidate in DGC."

28522256

➶

reach

"All 4 of the BAP1 somatic mutations found in EODGC-WES were associated with loss of heterozygosity, and BAP1 over-expression suppressed the growth of DGC cells (XREF_FIG)."

28522256

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...